Latest Pharma Insights
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the...
Scrip - March 27, 2024
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the...
Scrip - March 27, 2024
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their...
Medtech Insight - March 27, 2024
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their...
Medtech Insight - March 27, 2024
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a...
Pink Sheet - March 27, 2024
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a...
Pink Sheet - March 27, 2024
Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to...
Pink Sheet - March 27, 2024
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to...
Pink Sheet - March 27, 2024
Moderna Touts mRNA Progress, Plus $750m From Blackstone To Back Its Flu Vaccine
Moderna still projects $4.5bn in R&D spending this year for its pipeline of 28 mRNA vaccines, including a COVID-19 vaccine...
Scrip - March 27, 2024
Moderna still projects $4.5bn in R&D spending this year for its pipeline of 28 mRNA vaccines, including a COVID-19 vaccine...
Scrip - March 27, 2024
Jurors' Answers In FTC Complaint Against Prevagen Might Form A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put...
HBW Insight - March 27, 2024
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put...
HBW Insight - March 27, 2024
Beckley Psytech Takes Another Step Toward Psychedelic Antidepressants
The private British biotech announced positive results from its Phase IIa study of BPL-003, which it said support its Phase...
Scrip - March 27, 2024
The private British biotech announced positive results from its Phase IIa study of BPL-003, which it said support its Phase...
Scrip - March 27, 2024
Biden vs Trump On Drug Pricing And Unfinished Business
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former...
Pink Sheet - March 27, 2024
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former...
Pink Sheet - March 27, 2024
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and...
Pink Sheet - March 27, 2024
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and...
Pink Sheet - March 27, 2024
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they...
HBW Insight - March 27, 2024
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they...
HBW Insight - March 27, 2024
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
Pink Sheet - March 27, 2024
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
Pink Sheet - March 27, 2024
Investor Faith In David Hung’s Nuvation Renewed By Anheart Buyout
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.
Scrip - March 27, 2024
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.
Scrip - March 27, 2024
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations...
Pink Sheet - March 27, 2024
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations...
Pink Sheet - March 27, 2024
Medicines For Europe Responds To New EU Biotech Initiative
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
C4XD Delisting Highlights Funding Frustration For UK Biotechs
The Manchester-based group has had enough of being undervalued in the public markets and is going private again.
Scrip - March 27, 2024
The Manchester-based group has had enough of being undervalued in the public markets and is going private again.
Scrip - March 27, 2024
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
HBW Insight - March 27, 2024
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
HBW Insight - March 27, 2024
Henlius Reports First Fully Profitable Year After Past Losses
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
FDA Takes Another Swing At Banning Electrical Shock Devices
The US FDA wants to ban devices that use an electrical shock to stop aggressive behavior. The agency attempted to...
Medtech Insight - March 27, 2024
The US FDA wants to ban devices that use an electrical shock to stop aggressive behavior. The agency attempted to...
Medtech Insight - March 27, 2024
Vertex Joins Regulus In Kidney Disease Therapy Hunt
The Boston, MA biotech is about to enter the clinic with its autosomal dominant polycystic kidney disease candidate but microRNA...
Scrip - March 27, 2024
The Boston, MA biotech is about to enter the clinic with its autosomal dominant polycystic kidney disease candidate but microRNA...
Scrip - March 27, 2024
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Open For Business: Sandoz’s Austrian Antibiotic Facility Is Ready To Serve
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed...
Medtech Insight - March 27, 2024
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed...
Medtech Insight - March 27, 2024
Proposed US BIOSECURE Act - Do Lonza, Other CDMOs Gain And How Soon?
Concerns over the impact of the proposed US BIOSECURE Act on the CRO and CDMO segments linger despite proponent Mike...
Scrip - March 27, 2024
Concerns over the impact of the proposed US BIOSECURE Act on the CRO and CDMO segments linger despite proponent Mike...
Scrip - March 27, 2024
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Pink Sheet - March 27, 2024
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Pink Sheet - March 27, 2024
China Biotech IPO Drought Lingers But HK Sees First Of 2024
Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is...
Scrip - March 27, 2024
Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is...
Scrip - March 27, 2024
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value...
HBW Insight - March 27, 2024
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value...
HBW Insight - March 27, 2024
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the...
Scrip - March 27, 2024
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the...
Scrip - March 27, 2024
Moderna Touts mRNA Progress, Plus $750m From Blackstone To Back Its Flu Vaccine
Moderna still projects $4.5bn in R&D spending this year for its pipeline of 28 mRNA vaccines, including a COVID-19 vaccine...
Scrip - March 27, 2024
Moderna still projects $4.5bn in R&D spending this year for its pipeline of 28 mRNA vaccines, including a COVID-19 vaccine...
Scrip - March 27, 2024
Beckley Psytech Takes Another Step Toward Psychedelic Antidepressants
The private British biotech announced positive results from its Phase IIa study of BPL-003, which it said support its Phase...
Scrip - March 27, 2024
The private British biotech announced positive results from its Phase IIa study of BPL-003, which it said support its Phase...
Scrip - March 27, 2024
Investor Faith In David Hung’s Nuvation Renewed By Anheart Buyout
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.
Scrip - March 27, 2024
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.
Scrip - March 27, 2024
C4XD Delisting Highlights Funding Frustration For UK Biotechs
The Manchester-based group has had enough of being undervalued in the public markets and is going private again.
Scrip - March 27, 2024
The Manchester-based group has had enough of being undervalued in the public markets and is going private again.
Scrip - March 27, 2024
Vertex Joins Regulus In Kidney Disease Therapy Hunt
The Boston, MA biotech is about to enter the clinic with its autosomal dominant polycystic kidney disease candidate but microRNA...
Scrip - March 27, 2024
The Boston, MA biotech is about to enter the clinic with its autosomal dominant polycystic kidney disease candidate but microRNA...
Scrip - March 27, 2024
Proposed US BIOSECURE Act - Do Lonza, Other CDMOs Gain And How Soon?
Concerns over the impact of the proposed US BIOSECURE Act on the CRO and CDMO segments linger despite proponent Mike...
Scrip - March 27, 2024
Concerns over the impact of the proposed US BIOSECURE Act on the CRO and CDMO segments linger despite proponent Mike...
Scrip - March 27, 2024
China Biotech IPO Drought Lingers But HK Sees First Of 2024
Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is...
Scrip - March 27, 2024
Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is...
Scrip - March 27, 2024
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a...
Pink Sheet - March 27, 2024
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a...
Pink Sheet - March 27, 2024
Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to...
Pink Sheet - March 27, 2024
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to...
Pink Sheet - March 27, 2024
Biden vs Trump On Drug Pricing And Unfinished Business
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former...
Pink Sheet - March 27, 2024
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former...
Pink Sheet - March 27, 2024
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and...
Pink Sheet - March 27, 2024
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and...
Pink Sheet - March 27, 2024
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
Pink Sheet - March 27, 2024
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
Pink Sheet - March 27, 2024
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations...
Pink Sheet - March 27, 2024
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations...
Pink Sheet - March 27, 2024
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Pink Sheet - March 27, 2024
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Pink Sheet - March 27, 2024
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their...
Medtech Insight - March 27, 2024
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their...
Medtech Insight - March 27, 2024
FDA Takes Another Swing At Banning Electrical Shock Devices
The US FDA wants to ban devices that use an electrical shock to stop aggressive behavior. The agency attempted to...
Medtech Insight - March 27, 2024
The US FDA wants to ban devices that use an electrical shock to stop aggressive behavior. The agency attempted to...
Medtech Insight - March 27, 2024
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed...
Medtech Insight - March 27, 2024
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed...
Medtech Insight - March 27, 2024
Jurors' Answers In FTC Complaint Against Prevagen Might Form A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put...
HBW Insight - March 27, 2024
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put...
HBW Insight - March 27, 2024
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they...
HBW Insight - March 27, 2024
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they...
HBW Insight - March 27, 2024
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
HBW Insight - March 27, 2024
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
HBW Insight - March 27, 2024
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value...
HBW Insight - March 27, 2024
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value...
HBW Insight - March 27, 2024
Medicines For Europe Responds To New EU Biotech Initiative
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
Henlius Reports First Fully Profitable Year After Past Losses
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Open For Business: Sandoz’s Austrian Antibiotic Facility Is Ready To Serve
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
J&J Refines Direction For Ottava
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and...
In Vivo - March 26, 2024
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and...
In Vivo - March 26, 2024